SOLUTIONS PRODUCTS INNOVATION INVESTORS ESG
0
Add to list
GB COVID-19 Ag POCT
Cat. No. 4ECO101E
More details>
(3 items)
SOLUTIONS PRODUCTS INNOVATION INVESTORS ESG About GBC Our Brands R&D Media Join us Contact us
English 繁體中文
Menu
In Vitro Diagnostics (IVD)
Solutions
Blood Screening
Biomaterial
ELISA Immunoassay
A broad range of assays based on ELISA technology with systems solutions to meet your testing needs
Chemiluminescence Immunoassay
A broad range of assays based on Chemiluminescence (CLIA) technology with systems solutions to meet your testing needs
Molecular Diagnostics
Clinical solutions for infectious diseases and sexual health
Point of Care Testing
Fast testing results that can be used outside of the laboratory. Both qualitative and quantitative technologies are offered.
Cell Diagnostics
Liquid biopsy in Circulating Tumor Cells (CTCs) offering an non-invasive testing to screen abnormal cells, monitoring and validating treatment.
COVID-19 Solution
Digital Pathology
CDMO BY GBC
Hepatitis & HIV ELISA
Antibody Biomaterials
Human Plasma
About GBC
Our Story Leadership HIstory Award & Recognition Locations
Solutions
COVID-19 Solution Digital Pathology CDMO BY GBC
Products
In Vitro Diagnostics (IVD) Solutions Blood Screening Biomaterial
Our Brands
GB Pharma CurieMed Danner Lab
R & D
Pharma Diagnostic Solution
Innovation
ESG
Investors
About Us Reporting Corporate Governance FAQ
My Account
Media
Press Release/Events Award & Recognition Marketing Downloads
Join Us
Contact Us
Documentation
Copyright © 2024 General Biologicals Corporation
Privacy Policy Terms of Use